| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-15 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-15 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-12 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |